Could Synapse Discovery Help Slow Brain Aging and Alzheimer’s Disease?

0Comments

Scientists at the University of Colorado Anschutz Medical Campus recently discovered a previously unknown stability in synapses in the central nervous system (CNS) that they predict could hold therapeutic potential for brain disorders.

The study, published in Neuron, honed in on how information is transmitted between neurons in the CNS. Neurons, or nerve cells, use electric impulses and chemical signals to transmit information, connecting with each other at junctions called synapses. In diseases such as Alzheimer’s disease, cognitive decline and memory dysfunction are a result of a failure in synapses.

Neurons connect to other neurons in two ways: 1) the growth of axons, which are extensions from the neuron, and 2) the growth of dendrites, which are tree-like extensions of the neural cell body. The study focused on dendritic spines, small protrusions that grow from the dendrites and help store and transmit information to the neuron’s cell body.

 A single neuron with its cell body, dendrites and dendritic spines (the sites of synapses) illuminated.

“Dendritic spines are extremely important,” said Matthew Kennedy, PhD, professor of Pharmacology in the University of Colorado School of Medicine, who is one of the study’s co-lead authors along with Won Chan Oh, PhD, also in the Department of Pharmacology. “In diseases like Alzheimer’s disease, these spines disappear. In other brain disorders, like autism spectrum disorders, there can be more of these spines. In schizophrenia, these spines can be shaped differently, and we know the shape controls the spine’s function.”

Strength of synapses critical to brain function

Dendritic spines are dynamic – constantly shrinking and growing naturally – a characteristic important to memory. When people learn a new behavioral task, the dendritic spines get bigger, sometimes growing in numbers. The spines play a role in brain plasticity, the ability to restructure in response to stimuli, and are thought to underlie memory formation.

As dendritic spines grow, strong synapses form. “Synapses are how neurons communicate with each other,” Kennedy said. “When you feel an emotion, have a thought, or do a behavior, it’s represented in your brain by an ensemble of neurons that are essentially firing at the same time – they’re talking to each other.”

The strength of these synapses is important for how circuits communicate in the brain. When fewer synapses occur, it’s more difficult for a person to learn or remember things

Study pinpoints different class of synapses

Dendritic spines represent the point of contact for excitatory synapses. If enough of the spines are activated at the same time, the synapses cause the neuron to “fire,” also known as “action potential” (e.g. how all the neurons fire in a coordinated way to allow a person to pick up a glass and take a drink of water).

The Kennedy and Oh teams focused on a subset of dendritic spines that are contacted directly by axons from both an excitatory cell and an inhibitory cell.

“Inhibitory neurons put the brakes on things and make sure that the neural circuitry in your brain doesn’t go haywire,” Kennedy said, citing how disease states such as epilepsy and seizures occur due to inhibitory neural dysfunction. “Their synapses tend to be on the dendrites, but not directly onto these dendritic spines,” he said.

Excitatory (green) and inhibitory (red) connections make a dendritic spine more stable than a spine with only an excitatory connection. (Dashed line outlines the dendrite.)

“So we’ve known that dendritic spines are morphing around, getting bigger, encoding memories, and things like that. But we focused on a different class of synapses that have both an inhibitory and excitatory input onto it from two different types of neurons,” Kennedy said, referring to a subset of dendritic spines that the team found to be extremely stable.

 “In other words, these spines don’t undergo the sorts of plasticity that we just talked about,” Kennedy said. “It’s as if the ‘go’ sign and the ‘stop’ sign have been placed right next to each other at the exact same time.”

Promising new discovery fuels further research

Kennedy said it’s a unique class of synapse that is not well studied. “Depending on the brain region you’re looking at, between 5% and 20% of the dendritic spines are contacted by both the ‘go’ signal and the ‘stop’ signal.”

Because these synapses represent stable points of synaptic connectivity, Kennedy speculates they may represent “hardwired” behaviors or indelible memories – a primary area of focus in his lab.

Kennedy believes a second implication of this work relates to known disease states where the dendritic spines disappear, such as Alzheimer’s disease. Because the Neuron study was conducted in healthy cell structures, it’s not known whether this normally stable class of dendritic spines will disappear in neurodegenerative diseases.

He’s also interested in understanding the stability of these “stop and go” dendritic spines.

“If we understood why they’re so stable, it’s possible we could come up with a therapy that would be generally applicable to all synapses that could be potentially therapeutic for preserving synaptic connectivity in diseases like Alzheimer’s or even in the aging brain.”

Original source can be found here



Related

Caleb Michaud, Acting Associate Commissioner for External Affairs of FDA

FDA inspects Silver Canyon Coffee in Boulder for compliance on April 22

FDA records note an inspection at Silver Canyon Coffee in Boulder conducted on April 22, focusing on food composition, standards, labeling, economics, and biological hazards associated with foodborne illnesses.

Jim Traficant, Chief of Staff of FDA

FDA cites Silver Canyon Coffee in Boulder during April 22 inspection

The Food and Drug Administration conducted an inspection of Silver Canyon Coffee in Boulder on April 22, citing the business once for plant maintenance issues and reviewing food standards, labeling and biological hazards, based on information from the FDA’s official website.

Dr. Mehmet Oz CMS Administrator

Alcohol and drug abuse treatment Medicaid spending in Boulder surges to nearly $500,000 in 2024

Boulder saw Medicaid spending for Alcohol and Drug Abuse Treatment services jump by 91.7% to $499,954 in 2024, highlighting changing service use and payment trends in the city.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Boulder Leader.